Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: Implications for common non-segmental vitiligo

Pigment Cell and Melanoma Research

Volumn 21, Issue 6, 2008, Pages 646-652

  Taïeb, Alain ^a   Morice Picard, Fanny ^a   Jouary, Thomas ^a   Ezzedine, Khaled ^a   Cario André, Muriel ^a   Gauthier, Yvon ^a  

^a NONE

Author keywords

Blaschko's lines; Melanocytes; Mosaicism; Vitiligo

Indexed keywords

ARTICLE; AUTOIMMUNITY; GENE EXPRESSION; HEREDITY; HETEROZYGOSITY LOSS; HUMAN; MOSAICISM; PHENOTYPE; VITILIGO;

HUMANS; MELANOCYTES; MOSAICISM; SKIN PIGMENTATION; VITILIGO;

EID: 56249147496     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00511.x     Document Type: Article

References (39)

1. Barona, M.I., Arrunátegui, A., Falabella, R. Alzate, A. (1995). An epidemiologic case-control study in a population with vitiligo. J. Am. Acad. Dermatol. 33, 621 625.
2. Basak, P., Adiloglu, A., Koc, I., Tas, T. Akkaya, V. (2008). Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study. J. Eur. Acad. Dermatol. Venereol. [Epub ahead of print].
3. Blaschko, A. (1901). A. "Die Nervenverteilung in der Haut in ihre Beziehung zu den Erkrankungen der Haut". Beilage zu den Verhandlungen der Deutschen Dermatologischen Gesellschaft VII Congress, Breslau.
4. Bondanza, S., Maurelli, R., Paterna, P., Migliore, E., Giacomo, F.D., Primavera, G., Paionni, E., Dellambra, E. Guerra, L. (2007). Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour. Pigment Cell Res. 20, 288 300.
5. Cario-André, M., Pain, C., Gauthier, Y. Taïeb, A. (2007). The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Pigment Cell Res. 20, 385 393.
6. Chen, Y.F., Chang, J.S., Yang, P.Y., Hung, C.M., Huang, M.H. Hu, D.N. (2000). Transplant of cultured autologous pure melanocytes after laser-abrasion for the treatment of segmental vitiligo. J. Dermatol. 27, 434 439.
7. Gauthier, Y. (1995). The importance of Koebner's phenomenon in the induction of vitiligo vulgaris lesions. Eur. J. Dermatol. 5, 704 708.
8. Gauthier, Y., Cario André, M. Taïeb, A. (2003). A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res. 16, 322 332.
9. Hafner, C., van Oers, J.M., Vogt, T., Landthaler, M., Stoehr, R., Blaszyk, H., Hofstaedter, F., Zwarthoff, E.C. Hartmann, A. (2006). Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J. Clin. Invest. 116, 2201 2207.
10. Halder, R.M., Grimes, P.E., Cowan, C.A., Enterline, J.A., Chakrabarti, S.G. Kenney Jr., J.A. (1987). Childhood vitiligo. J. Am. Acad. Dermatol. 16 (5 Pt 1 948 954.
11. Hann, S.K. Lee, H.J. (1996). Segmental vitiligo: clinical findings in 208 patients. J. Am. Acad. Dermatol. 35 (5 Pt 1 671 674.
12. Happle, R. (1985). Lyonization and the lines of Blaschko. Hum. Genet. 70, 200 206.
13. Happle, R. (2001). Segmental type 2 manifestation of autosome dominant skin diseases. Development of a new formal genetic concept. Hautarzt 52, 283 287 (in German).
14. Happle, R. (2004). Patterns on the skin. New aspects of their embryologic and genetic causes. Hautarzt 55, 960 961 (in German).
15. Happle, R. (2007). Superimposed segmental manifestation of polygenic skin disorders. J. Am. Acad. Dermatol. 57, 690 699.
16. Happle, R. Assim, A. (2001). The lines of Blaschko on the head and neck. J. Am. Acad. Dermatol. 44, 612 615.
17. Iacovelli, P., Sinagra, J.L., Vidolin, A.P., Marenda, S., Capitanio, B., Leone, G. Picardo, M. (2005). Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology 210, 26 30.
18. Jin, Y., Mailloux, C.M., Gowan, K., Riccardi, S.L., LaBerge, G., Bennett, D.C., Fain, P.R. Spritz, R.A. (2007). NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356, 1216 1225.
19. Kemp, E.H., Gawkrodger, D.J., MacNeil, S., Watson, P.F. Weetman, A.P. (1997). Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J. Invest. Dermatol. 109, 69 73.
20. Kim, Y.C., Kim, Y.J., Kang, H.Y., Sohn, S. Lee, E.S. (2008). Histopathologic features in vitiligo. Am. J. Dermatopathol. 30, 112 116.
21. Larsson, P.A. Liden, S. (1980). Prevalence of skin diseases among adolescents 12-16 years of age. Acta Derm. Venereol. 60, 415 423.
22. Moellmann, G., McGuire, J. Lerner, A.B. (1973). ltrastructure and cell biology of pigment cells. Intracellular dynamics and the fine structure of melanocytes with special reference to the effects of MSH and cyclic AMP on microtubules and 10-nm filaments. Yale J. Biol. Med. 1973, 46.
23. Morice-Picard, F., Boralevi, F., Lepreux, S., Labrèze, C., Lacombe, D. Taïeb, A. (2007). Severe linear form of granuloma annulare along Blaschko's lines preceding the onset of a classical form of granuloma annulare in a child. Br. J. Dermatol. 157, 1056 1058.
24. Mulekar, S.V., Al Issa, A., Asaad, M., Ghwish, B. Al Eisa, A. (2006). Mixed vitiligo. J. Cutan. Med. Surg. 10, 104 107.
25. Nazzaro, V., Ermacora, E., Santucci, B. Caputo, R. (1990). Epidermolytic hyperkeratosis: generalized form in children from parents with systematized linear form. Br. J. Dermatol. 122, 417 422.
26. Paller, A.S., Syder, A.J., Chan, Y.M., Yu, Q.C., Hutton, E., Tadini, G. Fuchs, E. (1994). Genetic and clinical mosaicism in a type of epidermal nevus. N. Engl. J. Med. 331, 1408 1415.
27. Palmer, C.N., Irvine, A.D., Terron-Kwiatkowski, A. et al. (2006). Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 38, 441 446.
28. Poblete-Gutiérrez, P., Wiederholt, T., König, A., Jugert, F.K., Marquardt, Y., Rübben, A., Merk, H.F., Happle, R. Frank, J. (2004). Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J. Clin. Invest. 114, 1467 1474.
29. Schallreuter, K.U. Pittelkow, M.P. (1988). Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin. Arch. Dermatol. Res. 280, 137 139.
30. Schallreuter, K.U., Krüger, C., Rokos, H., Hasse, S., Zothner, C. Panske, A. (2007). Basic research confirms coexistence of acquired Blaschkolinear Vitiligo and acrofacial Vitiligo. Arch. Dermatol. Res. 299, 225 230.
31. Schallreuter, K.U., Krüger, C., Würfel, B.A., Panske, A. Wood, J.M. (2008). From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int. J. Dermatol. 47, 743 753.
32. Spritz, R.A., Gowan, K., Bennett, D.C. Fain, P.R. (2004). Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am. J. Hum. Genet. 74, 188 191.
33. Strömberg, S., Björklund, M.G., Asplund, A., Rimini, R., Lundeberg, J., Nilsson, P., Pontén, F. Olsson, M.J. (2008). Transcriptional profiling of melanocytes from patients with vitiligo vulgaris. Pigment Cell Melanoma Res. 21, 162 171.
34. Taibjee, S.M., Bennett, D.C. Moss, C. (2004). Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. Br. J. Dermatol. 151, 269 282.
35. Taieb, A. (1999). Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Derm. 41, 177 180.
36. Taieb, A. (2000). Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res. 13, 41 47.
37. Taieb, A. (2007). NALP1 and the inflammasomes: challenging our perception of vitiligo and vitiligo-related autoimmune disorders. Pigment Cell Res. 20, 260 262.
38. Taïeb, A. Picardo, M., VETF Members 2007). The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 20, 27 35.
39. Wu, C.S., Yu, H.S., Chang, H.R., Yu, C.L., Yu, C.L. Wu, B.N. (2000). Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesions. J. Dermatol. Sci. 23, 53 62.